CN110724946A - Impure-phase-free Mg-Al LDH coating on surface of magnesium alloy and preparation method and application thereof - Google Patents
Impure-phase-free Mg-Al LDH coating on surface of magnesium alloy and preparation method and application thereof Download PDFInfo
- Publication number
- CN110724946A CN110724946A CN201911053990.4A CN201911053990A CN110724946A CN 110724946 A CN110724946 A CN 110724946A CN 201911053990 A CN201911053990 A CN 201911053990A CN 110724946 A CN110724946 A CN 110724946A
- Authority
- CN
- China
- Prior art keywords
- magnesium alloy
- phase
- ldh
- coating
- hetero
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C22/00—Chemical surface treatment of metallic material by reaction of the surface with a reactive liquid, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals
- C23C22/05—Chemical surface treatment of metallic material by reaction of the surface with a reactive liquid, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals using aqueous solutions
- C23C22/06—Chemical surface treatment of metallic material by reaction of the surface with a reactive liquid, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals using aqueous solutions using aqueous acidic solutions with pH less than 6
- C23C22/48—Chemical surface treatment of metallic material by reaction of the surface with a reactive liquid, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals using aqueous solutions using aqueous acidic solutions with pH less than 6 not containing phosphates, hexavalent chromium compounds, fluorides or complex fluorides, molybdates, tungstates, vanadates or oxalates
- C23C22/57—Treatment of magnesium or alloys based thereon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A61L27/047—Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
- A61L27/306—Other specific inorganic materials not covered by A61L27/303 - A61L27/32
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C22/00—Chemical surface treatment of metallic material by reaction of the surface with a reactive liquid, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals
- C23C22/82—After-treatment
- C23C22/83—Chemical after-treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/18—Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/02—Methods for coating medical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Abstract
The invention belongs to the technical field of surface modification of metal materials, and particularly discloses a non-impurity-phase Mg-Al LDH coating on the surface of a magnesium alloy, and a preparation method and application thereof. The method specifically comprises the steps of soaking the magnesium alloy in hydrofluoric acid, mixing the magnesium alloy with an alkaline solution of an aluminum source, and performing hydrothermal treatment to obtain the impurity-free Mg-Al LDH coating. The coating related by the invention is completed by hydrofluoric acid and hydrothermal treatment, and the method has the advantages of simple process, low cost, no need of special equipment and contribution to large-scale industrial production. The magnesium alloy modified by the method has obviously improved corrosion resistance, and cells grow well on the surface of the material.
Description
Technical Field
The invention belongs to the technical field of surface modification of metal materials, and particularly relates to a non-impurity-phase Mg-Al LDH coating on the surface of a magnesium alloy, and a preparation method and application thereof.
Technical Field
The medical metal materials widely used in clinic, such as titanium alloy, nickel titanium alloy and the like, are all non-degradable materials, and the implant needs to be taken out by a secondary operation, thereby bringing heavy mental and economic pressure to patients. Therefore, the development of novel degradable medical materials has important social and research significance. The magnesium alloy has complete degradability and the elastic modulus is close to that of bone tissues, and has the potential of becoming a next-generation medical implant material.
However, magnesium alloys have a low electrochemical potential and a too high corrosion rate. Too fast corrosion can generate hydrogen gas cavities around the implant, which is not beneficial to the healing of wound parts; in addition, the hydroxyl generated by corrosion can obviously raise the surrounding pH value and easily cause inflammatory reaction; more importantly, erosion leads to too rapid a reduction in the mechanical properties of the implant, which, if used as a bone implant, is highly likely to lead to implant failure. Therefore, improving the corrosion resistance of the medical magnesium alloy is a very critical step for the clinical application of the medical magnesium alloy.
Surface modification of magnesium alloys is a common method to improve their corrosion resistance. At present, a great deal of research is carried out on preparing a magnesium-based Layered Double Hydroxide (LDH) coating on the surface of a magnesium alloy so as to improve the corrosion resistance and biocompatibility of the material. However, most of the magnesium-based LDHs prepared in the research contain magnesium hydroxide phase, and the presence of magnesium hydroxide is not beneficial to the corrosion resistance of the coating to some extent (ACS appl. Mater. interfaces 2016, 835033-. There is also a study of preparing a loose magnesium hydroxide layer by putting a magnesium alloy in an aqueous solution in advance, then introducing carbon dioxide, and preparing a pure-phase Mg-Al LDH coating in situ on the surface of the magnesium alloy by hydrothermal treatment (Corrosion Science 2011,53, 3281-. The method has complicated steps and higher cost for introducing carbon dioxide. Therefore, a new simple and low-cost process needs to be developed to prepare pure-phase Mg-Al LDH coating on the surface of the magnesium alloy in situ.
Disclosure of Invention
In order to overcome the defects of the prior art, the invention mainly aims to provide a preparation method of a non-impurity-phase Mg-Al LDH coating on the surface of a magnesium alloy.
The invention further aims to provide a non-impurity-phase Mg-Al LDH coating on the surface of the magnesium alloy obtained by the method. The modified magnesium alloy material is expected to be used as a substitute for bone implant or other medical metal materials.
The invention further aims to provide the application of the impure phase-free Mg-Al LDH coating on the surface of the magnesium alloy in medical materials.
A preparation method of a non-impurity-phase Mg-Al LDH coating on the surface of a magnesium alloy specifically comprises the following steps:
and soaking the magnesium alloy in hydrofluoric acid, mixing the magnesium alloy with an alkaline solution of an aluminum source, and performing hydrothermal treatment to obtain the impurity-free Mg-Al LDH coating.
Before soaking, the magnesium alloy is preferably polished and leveled, and then a polished and leveled sample is cleaned by absolute ethyl alcohol and dried at room temperature;
the concentration of the hydrofluoric acid is 20-80 v/v%; the temperature of hydrofluoric acid during soaking is 25-60 ℃, and the soaking time is 6-72 h.
The aluminum source is at least one of aluminum nitrate, aluminum sulfate and aluminum acetate;
the alkaline solution is at least one of a sodium hydroxide aqueous solution and a potassium hydroxide aqueous solution.
The pH value of the alkaline solution containing the aluminum source is 10-13, and is preferably 12.8.
The molar concentration of the aluminum source in the alkaline solution containing the aluminum source is 0.01-0.1 mol/L, and preferably 0.02 mol/L.
The temperature of the hydrothermal treatment is 60-160 ℃, and the time is 5-15 h.
The Mg-Al LDH coating without impurity phase on the surface of the magnesium alloy prepared by the method.
The application of the non-impurity-phase Mg-Al LDH coating on the surface of the magnesium alloy in medical materials.
The invention has the technical effects that:
the surface of the modified magnesium alloy obtained by the treatment of the invention is pure-phase Mg-Al LDH, and does not contain magnesium fluoride or magnesium hydroxide impurity phase. The obtained coating has good corrosion resistance, and cells show good activity on the surface of the material. Compared with the prior art, the invention has the following beneficial effects: 1) the coating related by the invention is completed by hydrofluoric acid and hydrothermal treatment, and the method has the advantages of simple process, low cost, no need of special equipment and contribution to large-scale industrial production. 2) The magnesium alloy modified by the method has obviously improved corrosion resistance, and cells grow well on the surface of the material.
Drawings
FIG. 1 is a SEM image of AZ31 magnesium alloy after treatment of example 1(a), example 2(b), example 3(c), example 4(d), example 5(e) and example 6 (f).
FIG. 2 is an X-ray diffraction pattern of a sample obtained by post-treating AZ31 magnesium alloy according to examples 1-6; wherein (a) to (f) correspond to examples 1 to 6 in this order.
FIG. 3 shows the atomic percentages of Mg, Al and F elements on the surface of the samples of AZ31 magnesium alloy after treatment in examples 1-6.
FIG. 4 is a plot of potentiodynamic polarization in phosphate buffered saline for AZ31 magnesium alloy and samples treated in example 4.
FIG. 5 shows the change in pH of phosphate buffered saline when AZ31 magnesium alloy and the samples treated in example 4 were immersed in phosphate buffered saline.
FIG. 6 is a graph of dead and live staining of MC3T3-E1 cells after 3 days of surface culture of the magnesium alloy AZ31(a) and the sample treated in example 4 (b).
Detailed Description
The present invention will be described in further detail with reference to examples and drawings, but the embodiments of the present invention are not limited thereto.
The reagents used in the examples are commercially available without specific reference.
Example 1
And (3) sequentially removing surface oxide layers of AZ31 magnesium alloy sheets with the thickness of 2mm and the diameter of 10mm by using 600# and 1000# SiC abrasive paper, and then ultrasonically cleaning by using alcohol. Then, hydrothermal treatment was carried out, the hydrothermal solution was 50ml of 0.02M aluminum nitrate solution, and the pH was adjusted to 12.8 using sodium hydroxide or potassium hydroxide, and finally the reaction was carried out at 120 ℃ for 12 hours.
FIG. 1(a) is a scanning electron microscope image of the surface morphology of the magnesium alloy obtained by the modification treatment of the present example. As can be seen from the figure, the surface of the sample is covered by a layer of compact micro-nano sheet-shaped structure. Figure 2(a) shows the XRD pattern of the sample after treatment in this example. As can be seen from the figure, in addition to the diffraction peak of the metal Mg, the diffraction peaks of magnesium hydroxide and Mg-Al LDH are also detected, which shows that the magnesium alloy without pretreatment releases more magnesium ions in the hydrothermal process to generate a magnesium hydroxide phase. FIG. 3 shows the atomic percentages of Mg, Al and F elements on the surface of the sample after the treatment of this example. From the graph, it is understood that the F content of the sample surface is 0.
Example 2
And (3) sequentially removing surface oxide layers of AZ31 magnesium alloy sheets with the thickness of 2mm and the diameter of 10mm by using 600# and 1000# SiC abrasive paper, and then ultrasonically cleaning by using alcohol. The cleaned AZ31 magnesium alloy sheet was placed in a 40% hydrofluoric acid solution (by volume) and reacted at room temperature for 6 hours. Then, hydrothermal treatment was carried out, the hydrothermal solution was 50ml of 0.02M aluminum nitrate solution, and the pH was adjusted to 12.8 using sodium hydroxide or potassium hydroxide, and finally the reaction was carried out at 120 ℃ for 12 hours.
FIG. 1(b) is a scanning electron microscope image of the surface morphology of the magnesium alloy obtained by the modification treatment of the present example. As can be seen from the figure, the surface of the sample is covered by a layer of compact micro-nano sheet-shaped structure. Figure 2(b) shows the XRD pattern of the sample after treatment in this example. As can be seen from the figure, besides the diffraction peak of the metal Mg, the diffraction peaks of magnesium hydroxide and Mg-Al LDH are also detected, which shows that the magnesium fluoride generated in the hydrofluoric acid treatment process has insufficient protection on the substrate material of the magnesium alloy, and a large amount of magnesium ions are still dissolved out to react to generate the magnesium hydroxide. FIG. 3 shows the atomic percentages of Mg, Al and F elements on the surface of the sample after the treatment of this example. From the graph, it is understood that the F content of the sample surface is 0, which indicates that magnesium fluoride generated during the hydrofluoric acid treatment is completely dissolved during the hydrothermal process.
Example 3
And (3) sequentially removing surface oxide layers of AZ31 magnesium alloy sheets with the thickness of 2mm and the diameter of 10mm by using 600# and 1000# SiC abrasive paper, and then ultrasonically cleaning by using alcohol. The cleaned AZ31 magnesium alloy sheet was placed in a 40% hydrofluoric acid solution (by volume) and reacted at room temperature for 12 hours. Then, hydrothermal treatment was carried out, the hydrothermal solution was 50ml of 0.02M aluminum nitrate solution, and the pH was adjusted to 12.8 using sodium hydroxide or potassium hydroxide, and finally the reaction was carried out at 120 ℃ for 12 hours.
FIG. 1(c) is a scanning electron microscope image of the surface morphology of the magnesium alloy obtained by the modification treatment of the present example. As can be seen from the figure, the surface of the sample is covered by a layer of compact micro-nano sheet-shaped structure. Figure 2(c) shows the XRD pattern of the sample after treatment in this example. As can be seen from the figure, besides the diffraction peak of the metal Mg, the diffraction peaks of magnesium hydroxide and Mg-Al LDH are also detected, which shows that the magnesium fluoride generated in the hydrofluoric acid treatment process has insufficient protection on the substrate material of the magnesium alloy, and a large amount of magnesium ions are still dissolved out to react to generate the magnesium hydroxide. FIG. 3 shows the atomic percentages of Mg, Al and F elements on the surface of the sample after the treatment of this example. From the graph, it is understood that the F content of the sample surface is 0, which indicates that magnesium fluoride generated during the hydrofluoric acid treatment is completely dissolved during the hydrothermal process.
Example 4
And (3) sequentially removing surface oxide layers of AZ31 magnesium alloy sheets with the thickness of 2mm and the diameter of 10mm by using 600# and 1000# SiC abrasive paper, and then ultrasonically cleaning by using alcohol. The cleaned AZ31 magnesium alloy sheet was placed in a 40% hydrofluoric acid solution (by volume) and reacted at room temperature for 24 hours. Then, hydrothermal treatment was carried out, the hydrothermal solution was 50ml of 0.02M aluminum nitrate solution, and the pH was adjusted to 12.8 using sodium hydroxide or potassium hydroxide, and finally the reaction was carried out at 120 ℃ for 12 hours. The resulting sample was labeled LDH #.
FIG. 1(d) is a scanning electron microscope image of the surface morphology of the magnesium alloy obtained by the modification treatment of the present example. As can be seen from the figure, the surface of the sample is covered by a layer of compact micro-nano sheet-shaped structure. Figure 2(d) shows the XRD pattern of the sample after treatment in this example. As can be seen from the figure, only the diffraction peak of Mg-Al LDH was detected in addition to the diffraction peak of metallic Mg, indicating that the magnesium ions eluted from the magnesium alloy substrate and magnesium fluoride were all converted into Mg-Al LDH. FIG. 3 shows the atomic percentages of Mg, Al and F elements on the surface of the sample after the treatment of this example. From the graph, it is understood that the F content of the sample surface is 0, which indicates that magnesium fluoride generated during the hydrofluoric acid treatment is completely dissolved during the hydrothermal process.
Example 5
And (3) sequentially removing surface oxide layers of AZ31 magnesium alloy sheets with the thickness of 2mm and the diameter of 10mm by using 600# and 1000# SiC abrasive paper, and then ultrasonically cleaning by using alcohol. The cleaned AZ31 magnesium alloy sheet was placed in a 40% hydrofluoric acid solution (by volume) and reacted at room temperature for 36 hours. Then, hydrothermal treatment was carried out, the hydrothermal solution was 50ml of 0.02M aluminum nitrate solution, and the pH was adjusted to 12.8 using sodium hydroxide or potassium hydroxide, and finally the reaction was carried out at 120 ℃ for 12 hours.
FIG. 1(e) is a scanning electron microscope image of the surface morphology of the magnesium alloy obtained by the modification treatment of the present example. As can be seen from the figure, the surface of the sample is covered by a layer of compact micro-nano sheet-shaped structure. Figure 2(e) shows the XRD pattern of the sample after treatment in this example. As can be seen from the figure, only the diffraction peak of Mg-Al LDH was detected in addition to the diffraction peak of metallic Mg, indicating that the magnesium ions eluted from the magnesium alloy substrate and magnesium fluoride were all converted into Mg-Al LDH. FIG. 3 shows the atomic percentages of Mg, Al and F elements on the surface of the sample after the treatment of this example. As can be seen from the graph, the F content on the surface of the sample was about 2 at%, indicating that magnesium fluoride formed during the hydrofluoric acid treatment was not completely dissolved during the hydrothermal treatment.
Example 6
And (3) sequentially removing surface oxide layers of AZ31 magnesium alloy sheets with the thickness of 2mm and the diameter of 10mm by using 600# and 1000# SiC abrasive paper, and then ultrasonically cleaning by using alcohol. The cleaned AZ31 magnesium alloy sheet was placed in a 40% hydrofluoric acid solution (by volume) and reacted at room temperature for 72 hours. Then, hydrothermal treatment was carried out, the hydrothermal solution was 50ml of 0.02M aluminum nitrate solution, and the pH was adjusted to 12.8 using sodium hydroxide or potassium hydroxide, and finally the reaction was carried out at 120 ℃ for 12 hours.
FIG. 1(f) is a scanning electron microscope image of the surface morphology of the magnesium alloy obtained by the modification treatment of the present example. As can be seen from the figure, the surface of the sample is covered by a layer of compact micro-nano sheet-shaped structure. Figure 2(f) shows the XRD pattern of the sample after treatment in this example. As can be seen from the figure, only the diffraction peak of Mg-Al LDH was detected in addition to the diffraction peak of metallic Mg, indicating that the magnesium ions eluted from the magnesium alloy substrate and magnesium fluoride were all converted into Mg-Al LDH. FIG. 3 shows the atomic percentages of Mg, Al and F elements on the surface of the sample after the treatment of this example. As can be seen from the graph, the F content on the surface of the sample was about 2 at%, indicating that magnesium fluoride formed during the hydrofluoric acid treatment was not completely dissolved during the hydrothermal treatment.
Example 7
The AZ31 magnesium alloy and LDH # samples were subjected to electrochemical testing. The etching solution used was Phosphate Buffer (PBS), and the test temperature was room temperature. The instrument used was an electrochemical workstation (Shanghai Chenghua CHI 760C). The test sample is a working electrode, the graphite rod is a counter electrode, and the calomel electrode is a reference electrode.
FIG. 4 is a plot of zeta potential polarization of magnesium alloy and LDH # samples in PBS. As can be seen from the graph, although the LDH # sample had a reduced self-corrosion voltage compared to the AZ31 magnesium alloy, its self-corrosion current density was also reduced by 2 orders of magnitude (2.24X 10)-5VS 9.72×10-7A/cm2). And the polarization resistances calculated according to Tafel extrapolation are 5.40X 10, respectively4And 1.39X 106Ω/cm2. The above results show that the corrosion resistance of the modified sample is significantly improved by example 4.
Example 8
AZ31 magnesium alloy and LDH # samples were soaked in 10mL PBS solution, four replicates per group. The PBS solutions were tested for pH change on days 1, 3, 5 and 7, respectively, with a fresh PBS solution being replaced after each test.
FIG. 5 shows the change in pH of PBS buffer. As can be seen, the LDH # sample had a smaller effect on the pH of the PBS solution than the AZ31 magnesium alloy, indicating that the substrate was corroded to a lesser extent.
Example 9
The influence of AZ31 magnesium alloy and LDH # samples on normal cell activity was evaluated using mouse osteoblast MC3T3-E1 in vitro culture experiments. The specific method comprises the following steps:
1) placing the sample subjected to ultraviolet sterilization for 12 hours into a 24-well culture plate, and dripping 1mL of the sample with the density of 5 × 10 into each well4cell/mL cell suspension;
2) place the cell culture plate in 5% CO2Culturing at 37 deg.C in cell culture box with saturated humidity;
3) After 3 days of culture, live and dead cells were stained with calcein and propidium iodide, respectively, and observed with a laser confocal microscope (CLSM).
FIGS. 6(a) and (b) are dead and live staining patterns of MC3T3-E1 cells after 3 days of culture on the surface of magnesium alloy and LDH # samples, respectively. From the graph, it was found that the surface values of the AZ31 sample detected the presence of dead cells, whereas the LDH # sample surface detected the presence of a large number of live cells, covering almost the entire sample surface. The above results show that the magnesium alloy surface modified in example 4 has good cell compatibility. Is expected to be applied in the field of medical magnesium alloy surface modification.
The above embodiments are preferred embodiments of the present invention, but the present invention is not limited to the above embodiments, and any other changes, modifications, substitutions, combinations, and simplifications which do not depart from the spirit and principle of the present invention should be construed as equivalents thereof, and all such changes, modifications, substitutions, combinations, and simplifications are intended to be included in the scope of the present invention.
Claims (9)
1. A preparation method of a non-impurity-phase Mg-Al LDH coating on the surface of a magnesium alloy is characterized by comprising the following steps:
and soaking the magnesium alloy in hydrofluoric acid, mixing the magnesium alloy with an alkaline solution of an aluminum source, and performing hydrothermal treatment to obtain the impurity-free Mg-Al LDH coating.
2. The method for preparing the non-hetero-phase Mg-Al LDH coating on the surface of the magnesium alloy as claimed in claim 1, wherein the method comprises the following steps:
the concentration of the hydrofluoric acid is 20-80 v/v%; the temperature of hydrofluoric acid during soaking is 25-60 ℃, and the soaking time is 6-72 h.
3. The process for the preparation of a non-hetero-phase Mg-Al LDH coating for magnesium alloy surfaces as claimed in any of the claims 1 or 2, wherein:
the aluminum source is at least one of aluminum nitrate, aluminum sulfate and aluminum acetate;
the alkaline solution is at least one of a sodium hydroxide aqueous solution and a potassium hydroxide aqueous solution.
4. The method for preparing the non-hetero-phase Mg-Al LDH coating on the surface of the magnesium alloy as claimed in claim 1, wherein the method comprises the following steps:
the pH value of the alkaline solution containing the aluminum source is 10-13;
the molar concentration of the aluminum source in the alkaline solution containing the aluminum source is 0.01-0.1 mol/L.
5. The method for preparing the non-hetero-phase Mg-Al LDH coating on the surface of the magnesium alloy as claimed in claim 1, wherein the method comprises the following steps:
the pH of the alkaline solution containing the aluminum source is 12.8;
the molar concentration of the aluminum source in the alkaline solution containing the aluminum source is 0.02 mol/L.
6. The method for preparing the non-hetero-phase Mg-Al LDH coating on the surface of the magnesium alloy as claimed in claim 1, wherein the method comprises the following steps:
the temperature of the hydrothermal treatment is 60-160 ℃, and the time is 5-15 h.
7. The method for preparing the non-hetero-phase Mg-Al LDH coating on the surface of the magnesium alloy as claimed in claim 1, wherein the method comprises the following steps:
before soaking, the magnesium alloy is firstly polished to be flat, and then a sample after polishing to be flat is cleaned by adopting absolute ethyl alcohol and dried at room temperature.
8. A non-hetero-phase Mg-Al LDH coating on the surface of the magnesium alloy prepared by the method of any one of claims 1 to 7.
9. The use of a non-hetero-phase Mg-Al LDH coating on the surface of the magnesium alloy as claimed in claim 8 in medical materials.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911053990.4A CN110724946A (en) | 2019-10-31 | 2019-10-31 | Impure-phase-free Mg-Al LDH coating on surface of magnesium alloy and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911053990.4A CN110724946A (en) | 2019-10-31 | 2019-10-31 | Impure-phase-free Mg-Al LDH coating on surface of magnesium alloy and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110724946A true CN110724946A (en) | 2020-01-24 |
Family
ID=69223538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911053990.4A Pending CN110724946A (en) | 2019-10-31 | 2019-10-31 | Impure-phase-free Mg-Al LDH coating on surface of magnesium alloy and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110724946A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113106439A (en) * | 2021-04-14 | 2021-07-13 | 广东工业大学 | Anti-corrosion composite coating on surface of magnesium alloy and preparation method and application thereof |
CN114836710A (en) * | 2022-05-20 | 2022-08-02 | 中国科学院兰州化学物理研究所 | Method for preparing anticorrosive coating on surface of magnesium alloy |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106567062A (en) * | 2016-10-20 | 2017-04-19 | 中国科学院上海硅酸盐研究所 | Surface modified magnesium alloy material with good corrosion resistance and biocompatibility and preparation method and application thereof |
CN106702238A (en) * | 2017-02-17 | 2017-05-24 | 中国科学院上海硅酸盐研究所 | Surface modified magnesium alloy material as well as preparation method thereof and application thereof |
CN107385419A (en) * | 2017-06-28 | 2017-11-24 | 河南工业大学 | Medical magnesium alloy surface is corrosion-resistant and the coating of hydrophilicity and preparation method thereof for a kind of raising |
KR20170135505A (en) * | 2016-05-31 | 2017-12-08 | 전북대학교산학협력단 | Method for hydrothermal treatment for surface treatment on magnesium alloy |
CN107740083A (en) * | 2017-10-31 | 2018-02-27 | 重庆理工大学 | A kind of preparation method of the super-hydrophobic fluorine conversion coating of Mg alloy surface |
CN107789665A (en) * | 2017-10-31 | 2018-03-13 | 重庆理工大学 | A kind of preparation method of the super-hydrophobic hydroxyapatite film layer of Mg alloy surface |
-
2019
- 2019-10-31 CN CN201911053990.4A patent/CN110724946A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170135505A (en) * | 2016-05-31 | 2017-12-08 | 전북대학교산학협력단 | Method for hydrothermal treatment for surface treatment on magnesium alloy |
CN106567062A (en) * | 2016-10-20 | 2017-04-19 | 中国科学院上海硅酸盐研究所 | Surface modified magnesium alloy material with good corrosion resistance and biocompatibility and preparation method and application thereof |
CN106702238A (en) * | 2017-02-17 | 2017-05-24 | 中国科学院上海硅酸盐研究所 | Surface modified magnesium alloy material as well as preparation method thereof and application thereof |
CN107385419A (en) * | 2017-06-28 | 2017-11-24 | 河南工业大学 | Medical magnesium alloy surface is corrosion-resistant and the coating of hydrophilicity and preparation method thereof for a kind of raising |
CN107740083A (en) * | 2017-10-31 | 2018-02-27 | 重庆理工大学 | A kind of preparation method of the super-hydrophobic fluorine conversion coating of Mg alloy surface |
CN107789665A (en) * | 2017-10-31 | 2018-03-13 | 重庆理工大学 | A kind of preparation method of the super-hydrophobic hydroxyapatite film layer of Mg alloy surface |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113106439A (en) * | 2021-04-14 | 2021-07-13 | 广东工业大学 | Anti-corrosion composite coating on surface of magnesium alloy and preparation method and application thereof |
CN114836710A (en) * | 2022-05-20 | 2022-08-02 | 中国科学院兰州化学物理研究所 | Method for preparing anticorrosive coating on surface of magnesium alloy |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kalaivani et al. | Effect of copper (Cu 2+) inclusion on the bioactivity and antibacterial behavior of calcium silicate coatings on titanium metal | |
Wang et al. | In vitro and in vivo studies on Ti-based bulk metallic glass as potential dental implant material | |
CN106702238B (en) | Modified magnesium alloy materials in a kind of surface and its preparation method and application | |
KR100775537B1 (en) | Method of fabricating implant with improved surface properties and implant fabiricated by the same method | |
Xue et al. | Superelasticity, corrosion resistance and biocompatibility of the Ti–19Zr–10Nb–1Fe alloy | |
CN110724946A (en) | Impure-phase-free Mg-Al LDH coating on surface of magnesium alloy and preparation method and application thereof | |
CN106567062B (en) | With modified magnesium alloy materials in the surface of good corrosion and biocompatibility and its preparation method and application | |
CN104888271A (en) | Method for preparing strontium-containing hydroxyapatite coating on surface of biodegradable magnesium alloy | |
Abdi et al. | Designing new biocompatible glass‐forming Ti75‐xZr10NbxSi15 (x= 0, 15) alloys: corrosion, passivity, and apatite formation | |
Tao et al. | Synthesis of a porous oxide layer on a multifunctional biomedical titanium by micro-arc oxidation | |
Capellato et al. | Surface modification on Ti-30Ta alloy for biomedical application | |
Mendolia et al. | Calcium phosphate/polyvinyl acetate coatings on SS304 via galvanic co-deposition for orthopedic implant applications | |
CN108969803B (en) | Medical degradable surface modified magnesium alloy with corrosion resistance, osteogenic differentiation promotion and antibacterial property and preparation method thereof | |
CN104274863B (en) | A kind of magnesium alloy/conversion film composite biological material | |
CN109295438A (en) | A kind of method that hydro-thermal prepares Mg alloy surface micro-nano structure hydroxyapatite coating layer | |
CN111494704B (en) | Method for preparing magnesium-based alloy biomaterial with small peptide coating and application thereof | |
Dinca et al. | Nickel–titanium alloy: Cytotoxicity evaluation on microorganism culture | |
CN101226136B (en) | Magnesium alloy microbial corrosion method based on solid medium | |
CN109778160A (en) | Medical magnesium alloy implant inorganic agent and its application method | |
CN102425000A (en) | Method for preparing biologically active titanium dioxide film on NiTi alloy surface | |
CN112121227A (en) | Preparation method of medical composite coating of strontium titanate/strontium hydroxyapatite on titanium metal surface | |
Li et al. | rBMSC and bacterial responses to isoelastic carbon fiber-reinforced poly (ether-ether-ketone) modified by zirconium implantation | |
CN110938812B (en) | Surface modified magnesium alloy with antibacterial property and preparation method and application thereof | |
Li et al. | Hydrothermal growth of TiO 2-CaP nano-films on a Ti–Nb-based alloy in concentrated calcium phosphate solutions | |
CN1233424C (en) | Bionic preparing method for depositing calcium and phosphor active layer on memory alloy of nickel and titanium for medical use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200124 |